ghk cu research GHK-Cu Peptide GHK-CU - 50mg

The same mechanism that extends the replicative life of healthy cells also supports the proliferation of cancer cells, which are defined by their ability to bypass normal telomere-based growth limits

This supports reliable experimental outcomes and consistent research performance

Trials of the glow stack involved subjects dosing the product at 1.25mg every two days, rotating between both thighs, arms and stomach area

Thus, it can be hypothesized that the ability of DSIP to maintain efficiency of oxidative phosphorylation, even in the setting of hypoxia, could make the peptide a subject of interest for conditions such as stroke and heart attack in future research